Tag: Wayritz

Long-term dual antiplatelet therapy does not increase mortality risk

Sanofi wins approval for first Bruton’s tyrosine kinase inhibitor in immune thrombocytopenia

byDeepti Shroff

September 9, 2025

1. The FDA approved rilzabrutinib, branded Wayrilz, as the first BTK (Bruton’s tyrosine kinase) inhibitor for adults with ITP (immune ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo
2 Minute Medicine Rewind November 10th, 2025
Concomitant use of direct oral anticoagulants and interacting antiarrhythmic drugs and the risk of stroke and bleeding among patients with non-valvular atrial fibrillation: a multinational cohort study

No Result

View All Result